Y Biologics
Scope
Date
~
-
Shareholder value
Samsung leader Lee calls on mgt to raise shareholder value
Samsung Electronics Co. set up a task force team dedicated to increasing its shareholder value last month, according to industry sources on Oct. 4. ...
Oct 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Samsung C&T extends investment in US biotech firms
The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...
Aug 17, 2022 (Gmt+09:00)
-
Samsung Group
Samsung Group to speed up corporate governance reform
Samsung Group, South Korea’s largest conglomerate, is expected to accelerate the restructuring of its corporate governance to help Vice Chairm...
Aug 15, 2022 (Gmt+09:00)
-
Carbon neutrality
Samsung Electronics to announce plans to join RE100 Initiative
Samsung Electronics Co., the world’s largest smartphone and memory chipmaker, will soon join The Climate Group’s RE100 Initiative as the...
Aug 14, 2022 (Gmt+09:00)
-
Samsung Group
Samsung’s Lee reinstated; big moves in store for top conglomerate
Lee Jae-yong, Samsung Group’s de facto leader, on Friday had his right to work restored, paving the way for big moves for South Korea’s ...
Aug 12, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double CDMO capacity with new plants worth $5.3 bn
Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...
Jul 18, 2022 (Gmt+09:00)
-
Electric vehicles
Hyundai’s IONIQ 6 travels faster, farther than Tesla Model Y, Mercedes EQS
BUSAN – Hyundai Motor Co. has launched the IONIQ 6, its first fully electric sedan, which it claims runs faster and boasts a longer range than...
Jul 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Jun 07, 2022 (Gmt+09:00)
language -
Korean chipmakers
Samsung Elec. executes surprise chip executive reshuffle
Samsung Electronics Co. undertook an unexpected personnel reshuffle on Thursday, involving 20 employees, to hold them accountable for a lower-than-e...
Jun 03, 2022 (Gmt+09:00)
language -
Business & Politics
Yoon, Biden highlight 'economic security alliance' following Samsung tour
South Korean President Yoon Suk-yeol and visiting US President Joe Biden emphasized the two countries' iron-clad commitment to economic security all...
May 20, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Lotte to buy BMS' biologics plant in Syracuse for $160 mn
South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...
May 13, 2022 (Gmt+09:00)
-
The KED View
Time for Samsung to get another Fukuda Report
Eight years ago today, the late Samsung Group leader Lee Kun-hee collapsed at his home following a heart attack, a harbinger of doom six years later...
May 10, 2022 (Gmt+09:00)
-
Samsung Group
Jay Y. Lee absence raises risks for Samsung chip biz
Samsung Electronics Co. is losing its hegemony in the global semiconductor market as a sustained leadership vacuum has kept the world’s top me...
Apr 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Kolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
-
Rights offerings
Samsung Biologics to raise $2.6 bn in rights issue
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO) and a biotech division under the Samsung Group, is set ...
Apr 12, 2022 (Gmt+09:00)
-
Samsung Group
Samsung Group hires governance expert for unprecedented reorganization
Samsung Electronics Co. has hired a 20-year governance veteran for its much-awaited corporate governance restructuring, according to those familia...
Apr 11, 2022 (Gmt+09:00)
-
War in Ukraine
Korea jittery over oil, gas, commodity weaponization
South Korea’s energy and raw materials imports have surged to all-time highs in value terms in the wake of Russia’s invasion of Ukraine,...
Mar 13, 2022 (Gmt+09:00)
-
Private equity
IMM to buy Samsung Life stake once owned by Jay Y. Lee's sister
IMM Private Equity is set to acquire a 1.73 percent stake in Samsung Life Insurance Co., according to investment banking sources on Jan. 27. The sta...
Jan 27, 2022 (Gmt+09:00)
-
Electronics
Samsung Elec launches dedicated team for China
Samsung Electronics Co., South Korea’s top tech giant, has established a dedicated team for the Chinese market, where its smartphone and home ...
Dec 19, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung likely to announce US foundry investment plan this week
Samsung Electronics Co. is expected to announce an investment plan for its second US-based semiconductor foundry plant this week. As the South Kor...
Nov 22, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
Business & Politics
Jay Y. Lee meets Verizon CEO and Moderna co-founder
Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...
Nov 18, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Tech, Media & Telecom
Samsung's Lee to be released on parole on Aug. 13
Samsung Group leader Jay Y. Lee will be released on parole on Friday after having been imprisoned since January of this year on charges of bribery a...
Aug 09, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
Korean stock market
Samsung Electronics’ stock stages a rebound as outlook concerns ease
Shares of Samsung Electronics Co. have risen above the psychologically important level as foreign and institutional investors returned amid easing c...
Aug 04, 2021 (Gmt+09:00)
-
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)
Latest News
- 1 Samsung's financial arms beat No.1 banking group KB in profit
- 2 Korea’s airlines plagued by elevated fuel costs, strong dollar
- 3 LG Uplus offers Korean Air gift cards to 5G subscribers
- 4 SK Bioscience sells stake in US vaccine developer Novavax
- 5 Naver Cloud takes the lead in Korea’s public AI business